M&A Deal Summary

Vectron Biosolutions Acquires T3S Technologies - Bacterial Secretion Platform

On June 17, 2021, Vectron Biosolutions acquired life science company T3S Technologies - Bacterial Secretion Platform from T3S Technologies

Acquisition Highlights
  • This is Vectron Biosolutions’ 1st transaction in the Life Science sector.
  • This is Vectron Biosolutions’ 1st transaction in the United States.
  • This is Vectron Biosolutions’ 1st transaction in Utah.

M&A Deal Summary

Date 2021-06-17
Target T3S Technologies - Bacterial Secretion Platform
Sector Life Science
Buyer(s) Vectron Biosolutions
Sellers(s) T3S Technologies
Deal Type Divestiture

Target

T3S Technologies - Bacterial Secretion Platform

Salt Lake City, Utah, United States
T3S Technologies' Bacterial Secretion Platform provides solutions to life science industries.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Vectron Biosolutions

Trondheim, Norway

Category Company
Founded 2008
Sector Life Science
DESCRIPTION

Vectron Biosolutions provides the life science industry with superior technologies and solutions for robust and cost-efficient production of recombinant proteins in E. coli and other bacteria through a combination of experienced life science researchers, state-of-the-art laboratory facilities, a proprietary technology platform, and skillful management. Vectron Biosolutions was founded in 2008 and is based in Trondheim, Norway.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Utah) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1

Seller(S) 1

SELLER

T3S Technologies

Salt Lake City, Utah, United States

Category Company
Sector Life Science
DESCRIPTION

T3S Technologies is a developer of genetically engineered bacterial cells designed to provide treatment of chronic disease, based in Salt Lake City, Utah.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Utah) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1